Biocryst Pharmaceuticals Inc (BCRX)
Depreciation & Amortization
$5.95M
TTM · Period ending: · USD
BCRX Depreciation & Amortization
Latest reported$5.95Mperiod ending
Latest reported$5.95Mperiod ending
BCRX TTM Depreciation & Amortization ($600.00K → $5.95M)
TTM Depreciation & Amortization
High-resolution chart · PNG
BCRX depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 5,953,000 | |
| 5,769,000 | |
| 5,039,000 | |
| 1,304,000 | |
| 1,280,000 | |
| 1,271,000 | |
| 1,246,000 | |
| 1,360,000 | |
| 1,469,000 | |
| 1,556,000 | |
| 1,655,000 | |
| 1,628,000 | |
| 1,597,000 | |
| 1,525,000 | |
| 1,437,000 | |
| 1,212,000 | |
| 1,052,000 | |
| 916,000 | |
| 777,000 | |
| 786,000 | |
| 724,000 | |
| 708,000 | |
| 748,000 | |
| 753,000 | |
| 768,000 | |
| 766,000 | |
| 724,000 | |
| 737,000 | |
| 750,000 | |
| 760,000 | |
| 770,000 | |
| 754,000 | |
| 737,000 | |
| 718,000 | |
| 704,000 | |
| 694,000 | |
| 691,000 | |
| 608,000 | |
| 483,000 | |
| 354,000 | |
| 222,000 | |
| 182,000 | |
| 180,000 | |
| 177,000 | |
| 174,000 | |
| 169,000 | |
| 177,000 | |
| 194,000 | |
| 218,000 | |
| 260,000 | |
| 304,000 | |
| 414,000 | |
| 486,000 | |
| 557,000 | |
| 628,000 | |
| 717,000 | |
| 766,000 | |
| 829,000 | |
| 886,000 | |
| 1,800,369 | |
| 1,923,369 | |
| 2,101,369 | |
| 2,267,369 | |
| 1,492,514 | |
| 1,578,514 | |
| 1,593,514 | |
| 1,612,514 | |
| 1,679,878 | |
| 1,692,878 | |
| 1,663,878 | |
| 1,625,878 | |
| 1,780,713 | |
| 1,650,713 | |
| 1,510,713 | |
| 1,369,713 | |
| 980,195 | |
| 872,195 | |
| 847,195 | |
| 821,195 | |
| 800,567 | |
| 847,567 | |
| 845,567 | |
| 864,567 | |
| 900,449 | |
| 923,449 | |
| 949,449 | |
| 969,449 | |
| 974,000 | |
| 990,000 | |
| 1,041,000 | |
| 1,101,000 | |
| 1,159,618 | |
| 1,214,618 | |
| 1,263,618 | |
| 1,246,618 | |
| 1,239,435 | |
| 1,194,435 | |
| 1,101,435 | |
| 1,049,435 | |
| 911,214 |